Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors—data from a large national quality register

Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors—data from a large national quality register

Abstract Background There are limited data regarding efficacy of abatacept treatment for rheumatoid arthritis (RA) outside clinical trials. Quality registers have been useful for observational studies on tumor necrosis factor inhibition in clinical practice. The aim of this study was to investigate...

Full description

Bibliographic Details
Main Authors: Giovanni Cagnotto, Minna Willim, Jan-Åke Nilsson, Michele Compagno, Lennart T. H. Jacobsson, Saedis Saevarsdottir, Carl Turesson
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Arthritis Research & Therapy
Subjects:
Rheumatoid arthritis
Abatacept
Survival on drug
Treatment outcome
Response predictors
Online Access:https://doi.org/10.1186/s13075-020-2100-y

Internet

https://doi.org/10.1186/s13075-020-2100-y

Similar Items